Who owns AvKARE?
AvKARE is owned by Amneal (the United States, NASDAQ: AMRX), which has owned the brand since 2020.[1]
Amneal owns 65.1% of AvKARE rather than all of it.
Evidence: Amneal Pharmaceuticals, Inc. Annual Report on Form 10-K filed 2026-02-27, SEC EDGAR, 27 February 2026. Verified from filings; last checked .
Key facts
- Current owner
- Amneal Pharmaceuticals, Inc. (65.1% stake) verified
- Owned since
- Owner HQ
- 🇺🇸 United States, Bridgewater
- Origin
- 🇺🇸 United States
- Category
- Healthcare & pharma › Drug makers › Generics & biosimilars
- Parent ticker
- NASDAQ: AMRX
- Last verified
- · 1 sources
About AvKARE
AvKARE is a Tennessee-based supplier of pharmaceuticals to government agencies, chiefly the Department of Defense and the Department of Veterans Affairs, and a repackager and wholesaler to retail and institutional customers. Amneal's 2025 10-K says it acquired a 65.1% controlling interest in 2020; the sellers hold the other 34.9%.
Ownership timeline of AvKARE
Where AvKARE sits in Amneal
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Amneal ownership tree →
See the full Amneal brand portfolio (6) →
Other brands owned by Amneal
Amneal controls 6 brands on Brandtree, 6 of them in healthcare & pharma.
Also in healthcare & pharma
Other brands in drug makers, and who owns them
The 24 brands in drug makers on Brandtree belong to 6 owners. The largest is Gilead, with 5; Amneal has 4.
About the owner: Amneal
Amneal is a publicly listed company headquartered in Bridgewater, United States. Brandtree records 6 brands under its control, and it is listed as NASDAQ: AMRX.
Amneal Pharmaceuticals is a Bridgewater, New Jersey drugmaker whose 10-K for 2025 describes three segments: Affordable Medicines (generics, injectables and biosimilars), Specialty (branded products for central nervous system and endocrine disorders) and AvKARE, a pharmaceutical distributor. It had over 8,500 employees at 31 December 2025 and operates in the United States, India and Ireland.
🇺🇸 AvKARE and other American brands
Brandtree records a controlling owner for 2,399 brands that began in the United States. 461 of them (19%) are now controlled by a company headquartered in another country; AvKARE is not one of them.
Frequently asked questions
Who is the parent company of AvKARE?
The parent company of AvKARE is Amneal, a publicly listed company headquartered in the United States.
Is AvKARE American?
Yes. AvKARE originated in the United States and its owner, Amneal, is also headquartered in the United States.
Since when has Amneal owned AvKARE?
Amneal has owned AvKARE since 2020.
Is AvKARE still owned by Amneal?
Yes. As of 14 October 2026, AvKARE is still owned by Amneal (65.1% stake). The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Amneal Pharmaceuticals, Inc. Annual Report on Form 10-K filed 2026-02-27 — SEC EDGAR, SEC Form 10-K, published 27 February 2026; retrieved 14 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.